Clinical Trial Update: Phase 2 Trial of RGX-314 in Adults With Center Involved - Diabetic Macular Edema (CI - DME) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating RGX-314 for center-involved diabetic macular edema is currently recruiting in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• RGX-314

Snippet

Sponsor: Sierra Eye Associates | Conditions: Diabetic Macular Edema | Phase 2 | Status: RECRUITING